Article info

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

Authors

  1. Correspondence to Dr Sharon E Straus; sharon.straus{at}utoronto.ca
View Full Text

Citation

Tricco AC, Antony J, Khan PA, et al
Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

Publication history

  • Received May 23, 2014
  • Revised September 9, 2014
  • Accepted September 10, 2014
  • First published December 23, 2014.
Online issue publication 
October 25, 2017
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.